Designs for phase I trials in ordered groups

DOI10.1002/SIM.7133MaRDI QIDQ7002165zbMATH OpenFDO

Authors Mark R. Conaway, Nolan A. Wages

Publication date 4 April 2025

Published in Statistics in Medicine (Search for Journal in Brave)

Full work available at URL https://europepmc.org/articles/pmc5140690

zbMATH Keywords

cytotoxic agentdose-findingheterogeneous groups

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Cites work

• A comparative study of adaptive dose-finding designs for phase I oncology trials of combination therapies
• A dose-schedule finding design for phase I-II clinical trials
• Confidence interval estimation subject to order restrictions
• Continual reassessment method for ordered groups
• Continual Reassessment Method: A Likelihood Approach
• Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer
• Design efficiency in dose finding studies
• Designs for Single- or Multiple-Agent Phase I Trials
• Handbook of statistics in clinical oncology
• scientific article; zbMATH DE number 193111 (Why is no real title available?)
• Patient‐Specific Dose Finding Based on Bivariate Outcomes and Covariates
• Phase I design for completely or partially ordered treatment schedules
• TWO-SAMPLE CONTINUAL REASSESSMENT METHOD

Cited in

(2)

• A design for phase I trials in completely or partially ordered groups
• Preface. Early phase dose finding methodology

This page was built for publication: Designs for phase I trials in ordered groups

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q7002165)